{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:54:15Z","timestamp":1794725655915,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12887-018-1088-9","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T17:17:51Z","timestamp":1520961471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Severe eye complications from toxic epidermal necrolysis following initiation of Nevirapine based HAART regimen in a child with HIV infection: a case from Cameroon"],"prefix":"10.1186","volume":"18","author":[{"given":"Xavier","family":"Tchetnya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calypse Asangbe","family":"Ngwasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiayah","family":"Munge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold Ndemnge","family":"Aminde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"issue":"6","key":"1088_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M. The current understanding of Steven-Johson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7(6):803\u201315.","journal-title":"Expert Rev Clin Immunol"},{"key":"1088_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","volume":"94","author":"E Letko","year":"2005","unstructured":"Letko E, Papaliodis DN, Papaliodis GN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol. 2005;94:419\u201336. quiz 436\u2013418, 456","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"1088_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","volume":"26","author":"YS Chang","year":"2007","unstructured":"Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea. 2007;26(2):123\u20139.","journal-title":"Cornea"},{"issue":"8","key":"1088_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","volume":"91","author":"MV De Rojas","year":"2007","unstructured":"De Rojas MV, Dart JK, Saw VP. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol. 2007;91(8):1048\u201353.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1088_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ophtha.2010.06.035","volume":"118","author":"JS L\u00f3pez-Garc\u00eda","year":"2011","unstructured":"L\u00f3pez-Garc\u00eda JS, Rivas Jara L, Garc\u00eda-Lozano CI, Conesa E, de Juan IE. Murube del Castillo J. Ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis. Ophthalmology. 2011;118(2):265\u201371. [PubMed]","journal-title":"Ophthalmology"},{"issue":"19","key":"1088_CR6","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331(19):1272\u201385.","journal-title":"N Engl J Med"},{"issue":"1","key":"1088_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D397D8T291","volume":"8","author":"PD Ghislain","year":"2002","unstructured":"Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Steven-Johnson syndrome, toxic epidermal necrolysis and hypersentivity syndrome. Dermatol Online J. 2002;8(1):5.","journal-title":"Dermatol Online J"},{"issue":"4","key":"1088_CR8","first-page":"399","volume":"96","author":"J Thammakumpee","year":"2013","unstructured":"Thammakumpee J, Yongsiri S. Characteristics of toxic epidermal necrolysis and steven Johnson syndrome: a 5-year retrospective study. J Med Assoc Thail. 2013;96(4):399\u2013406.","journal-title":"J Med Assoc Thail"},{"key":"1088_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2165\/00044011-200525080-00005","volume":"25","author":"S Sabbatani","year":"2005","unstructured":"Sabbatani S, Manfredi R, Biagetti C, Chiodo F. Antiretroviral therapy in the real world;population-based pharmacoeconomic analysis of administration of anti-HIV regimens to 990 patients. Clin Drug Invest. 2005;25:527\u201335.","journal-title":"Clin Drug Invest"},{"issue":"1","key":"1088_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/0253-7613.75680","volume":"43","author":"S Haminder","year":"2011","unstructured":"Haminder S, Vinary KK, Bithika NK, Kalpana N. Nevirapine induced Steven-Johnson syndrome in an HIV infected patient. Indian J Pharmacol. 2011;43(1):84\u20136.","journal-title":"Indian J Pharmacol"},{"key":"1088_CR11","first-page":"156","volume":"3","author":"VL Lamani","year":"2015","unstructured":"Lamani VL, Kotinatot BC, Bhushan A. Nevirapine induced Steven-Johnson syndrome: a case report. Int J Acad Rev. 2015;3:156\u20138.","journal-title":"Int J Acad Rev"},{"key":"1088_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, et al. A method for estimating the probabiity of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"1088_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/PEC.0000000000000840","volume":"32","author":"S Alerhand","year":"2016","unstructured":"Alerhand S, Cassella C, Koyfman A. Steven-Johnson syndrome and toxic epidermal necrolysis in the pediatric population. Pediatr Emer Care. 2016;32:472\u20138.","journal-title":"Pediatr Emer Care"},{"issue":"5","key":"1088_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-4632.2012.05743.x","volume":"52","author":"B Saka","year":"2013","unstructured":"Saka B, Barro-Traor\u00e9 F, Atadokp\u00e9d\u00e9 FA. Steven-Johnson syndrome and toxic epidermal necrolysis in sub-saharan Africa: a multicentric study in four countries. Int J Dermatol. 2013;52(5):575\u20139.","journal-title":"Int J Dermatol"},{"key":"1088_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1067\/mjd.2001.101885","volume":"44","author":"DW Metry","year":"2001","unstructured":"Metry DW, Lahart CJ, Farmer KL, Hebert AA. Steven-Johnson syndrome caused by the antiretroviral drug nevirapine. J Am Acad Dermatol. 2001;44:354\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1088_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000336569","volume":"4","author":"MN Joseph","year":"2012","unstructured":"Joseph MN, Laura HS, Lynn FD. Severe antiretroviral therapy-induced toxic epidermal necrolysis in a child. Case Rep Dermatol. 2012;4:31\u20136.","journal-title":"Case Rep Dermatol"},{"issue":"6","key":"1088_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1468-1293.2006.00396.x","volume":"7","author":"W Manosuthi","year":"2006","unstructured":"Manosuthi W, Thongyen S, Chumpathat N. Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash. HIV Med. 2006;7(6):378\u201382.","journal-title":"HIV Med"},{"issue":"3","key":"1088_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1258\/ijsa.2008.008231","volume":"20","author":"S Kiertiburanakul","year":"2009","unstructured":"Kiertiburanakul S, Malathum K, Watcharananan S. Predicting factors for unsuccesful switching from nevirapine to efavirenz in HIV-infected patients who developed Nevirapine-associated skin rash. Int J STD AIDS. 2009;20(3):176\u20139.","journal-title":"Int J STD AIDS"},{"key":"1088_CR19","first-page":"68","volume":"166","author":"CJ Catt","year":"2016","unstructured":"Catt CJ, Hamilton GM, Fish J, Mireskandari K, Ali A. Ocular manifestations of Steven Johnson syndrome and toxic epidermal necrolysis in children. AJO. 2016;166:68\u201375.","journal-title":"AJO"},{"key":"1088_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","volume":"114","author":"C Sotozono","year":"2007","unstructured":"Sotozono C, Ang LP, Koizumi N, Higashihara H, Ueta M, Inatomi T, et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens Johnson syndrome. Ophthalmology. 2007;114:1294\u2013302.","journal-title":"Ophthalmology"},{"issue":"4","key":"1088_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4103\/0974-9233.142272","volume":"21","author":"L Van Zyl","year":"2014","unstructured":"Van Zyl L, Carrara H, Lecuona K. Prevalence of chronic ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis. Middle East Afr J Ophthalmol. 2014;21(4):332\u20135.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"5","key":"1088_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3341\/kjo.2013.27.5.331","volume":"27","author":"KH Kim","year":"2013","unstructured":"Kim KH, Park SW, Kim MK, Wee WR. Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Steven-Johnson syndrome. Korean J Ophthalmol. 2013;27(5):331\u201340.","journal-title":"Korean J Ophthalmol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-018-1088-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-018-1088-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-018-1088-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:51:25Z","timestamp":1693583485000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-018-1088-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1088"],"URL":"https:\/\/doi.org\/10.1186\/s12887-018-1088-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"26 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s father for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"108"}}